<DOC>
	<DOCNO>NCT00605267</DOCNO>
	<brief_summary>The purpose multi-centre , randomise , double-blind , parallel-group study compare efficacy safety anastrozole tamoxifen pre- post-operative administration goserelin acetate treatment premenopausal breast cancer patient</brief_summary>
	<brief_title>Arimidex/Tamoxifen Neo Adjuvant Study Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Premenopausal , estrogen receptor positive woman , age 20 year , operable measurable breast cancer provide write informed consent Medical history chemotherapy endocrine therapy breast cancer , treatment history radiotherapy . Unwillingness stop take drug know affect sex hormone status ( include hormone replacement therapy ( HRT ) .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Breast Neoplasms</keyword>
	<keyword>Tumors cancer human BREAST</keyword>
	<keyword>Tumor cancer human MAMMARY GLAND</keyword>
</DOC>